BBlogFlow

2nd Annual CPA Satellite Conference: Women’s Mental Health - Carleton University

·Oct 6, 2026
Source: Carleton University
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Every year, the Canadian Psychological Association’s Annual Convention creates opportunities for knowledge sharing, collaboration, and professional connection among more than 1,200 psychology professionals from across the country. Building on that success, the CPA Satellite Conference offers a different experience, giving attendees the chance to dive deeply into a single, pressing topic with richer engagement, meaningful conversations, and access to leading experts.

This year’s conference focuses on Women’s Mental Health. Psychology touches so many aspects of women’s lives, including menopause and work, gender-based violence, sex and sexuality, mental health across the gender/sex spectrum, intersectional mental health, motherhood, and more. Together, we will explore what psychological research and practice can tell us about these critical issues.

This article is an excerpt. To read the full content, visit the original source. Carleton University

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·